GEODE CAPITAL MANAGEMENT, LLC - CLEVELAND BIOLABS INC ownership

CLEVELAND BIOLABS INC's ticker is CBLI and the CUSIP is 185860202. A total of 22 filers reported holding CLEVELAND BIOLABS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of CLEVELAND BIOLABS INC
ValueSharesWeighting
Q2 2021$345,000
+48.1%
63,222
+42.2%
0.00%
Q1 2021$233,000
+288.3%
44,474
+152.7%
0.00%
Q4 2020$60,000
+76.5%
17,5980.0%0.00%
Q3 2020$34,000
-24.4%
17,5980.0%0.00%
Q2 2020$45,000
+55.2%
17,5980.0%0.00%
Q1 2020$29,000
+45.0%
17,598
-50.0%
0.00%
Q4 2019$20,000
+17.6%
35,196
+100.0%
0.00%
Q3 2019$17,000
-32.0%
17,5980.0%0.00%
Q2 2019$25,000
-7.4%
17,598
+5.5%
0.00%
Q1 2019$27,000
-15.6%
16,688
-50.0%
0.00%
Q4 2018$32,000
-3.0%
33,376
+100.0%
0.00%
Q3 2018$33,000
-19.5%
16,6880.0%0.00%
Q2 2018$41,000
-18.0%
16,6880.0%0.00%
Q1 2018$50,000
-24.2%
16,6880.0%0.00%
Q4 2017$66,000
+15.8%
16,6880.0%0.00%
Q3 2017$57,000
+16.3%
16,6880.0%0.00%
Q2 2017$49,000
+88.5%
16,6880.0%0.00%
Q1 2017$26,000
+13.0%
16,6880.0%0.00%
Q4 2016$23,000
-20.7%
16,6880.0%0.00%
Q3 2016$29,000
-38.3%
16,6880.0%0.00%
Q2 2016$47,000
+11.9%
16,6880.0%0.00%
Q1 2016$42,000
-27.6%
16,6880.0%0.00%
Q4 2015$58,000
+13.7%
16,688
+39.8%
0.00%
Q3 2015$51,00011,9370.00%
Other shareholders
CLEVELAND BIOLABS INC shareholders Q4 2020
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 320,053$1,104,0000.04%
Renaissance Technologies 165,651$571,0000.00%
VANGUARD GROUP INC 52,592$181,0000.00%
UBS Group AG 4,812$17,0000.00%
IFP Advisors, Inc 150$1,0000.00%
OSAIC HOLDINGS, INC. 290$1,0000.00%
BANK OF AMERICA CORP /DE/ 100$00.00%
PNC FINANCIAL SERVICES GROUP, INC. 15,000$52,0000.00%
WELLS FARGO & COMPANY/MN 34$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of CLEVELAND BIOLABS INC shareholders